Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, continues to make a distinctive, steadfast and positive impact on the widespread and…
China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI
China Medical University Hospital (CMUH) in Taiwan announced its collaboration with Google Cloud in mid-December 2023. Using Google Cloud’s generative AI technology, including MedLM, which is a large language model built on Med-PaLM 2, CMUH has developed a comprehensive “AI-assisted Physician” system which aims to assist…
Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process
Invitae (OTC: NVTA), a leading medical genetics company, announced today that it is building on previous actions to manage costs and improve its business structure by filing for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of New…
Lykos Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for MDMA-Assisted Therapy for PTSD
Lykos Therapeutics (formerly MAPS Public Benefit Corporation) (“Lykos”), a company dedicated to transforming mental healthcare, announced that the U.S. Food and Drug Administration (“FDA”) has accepted its new drug application (“NDA”) for midomafetamine capsules (“MDMA”) used in combination with psychological intervention,…
Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a novel Vitamin K Antagonist (VKA) for unmet needs in anticoagulation (blood thinning) therapy, today announced the appointment of Jeff Cole to the newly created position of Chief Operating Officer. In this role, Mr….
Giant Pharmacy Launches CPR Certification Program for Local Organizations and Businesses
Giant Food, the leading greater Washington, D.C. regional grocery chain, today announces the launch of its CPR Certification Program, a new service offered to local businesses and organizations. The program, offering two-year certifications led by Giant Food’s certified pharmacists, will provide the…
10 Fascinating Facts Redefining Robotic Heart Surgery
By Dr. Adil Sadiq, Head & Senior Consultant – Cardiothoracic & Vascular Surgery, Sakra World Hospital Bengaluru Robotic surgery is becoming increasingly popular, and the good news is, it’s not about replacing surgeons with machines. Instead, these robots assist surgeons by…
Human Change campaign launched at World Economic Forum in Davos to make children’s mental health a global priority
The global advocacy campaign, Human Change, was launched today in Davos at the World Economic Forum to raise awareness and drive transformation in the way children approach social media and the digitization of their lives. The campaign, founded by Margarita Louis-Dreyfus, brings together…
The Inner Circle Acknowledges, Bruce S. Fine Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care
Prominently featured in The Inner Circle, Bruce S. Fine is acknowledged as a Top Pinnacle Professional for his contributions to the field of Comprehensive Family Dental Care. Dr. Fine graduated from Muhlenberg College where he earned a Bachelor of Science degree. He then earned…
Endovascular Engineering’s Hēlo™ Thrombectomy System Receives IDE Approval to Start ENGULF Pivotal Trial for the Treatment of Pulmonary Embolism
Endovascular Engineering (“E2”), a medical device company focused on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism (VTE), announced today FDA Investigational Device Exemption (IDE) approval for its ENGULF US pivotal trial. This study will…
